Real-time enrollment status for this nerve injury clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 12:07 AM UTC
| NCT Number | NCT06616025 |
| Recruiting Status | Recruiting |
| Condition | Nerve Injury |
| Phase | PHASE3 |
| Target Enrollment | 98 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Neuraptive Therapeutics Inc. |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 13, 2026: Clinical trial NCT06616025 is currently recruiting participants. This phase3 study for nerve injury is actively seeking new participants at 25 locations across the United States. The study is sponsored by Neuraptive Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06616025 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06616025 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.